Search results
Results from the Health.Zone Content Network
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom. Vaccinations began on 8 December 2020 after Margaret Keenan became the first person in the world (outside trials) to receive her first dose of two of the ...
Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults – nine states, January-September 2021. https://www.cdc ...
The Joint Committee on Vaccination and Immunisation ( JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland ...
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicentre, randomised ...
Immunisation against infectious disease is popularly known as The Green Book, to provide information on the UK's vaccination schedule and vaccines for vaccine preventable infectious diseases. [1] [2] It is a guide for health professionals and health departments that give vaccines in the UK. [2] Updates are added by its clinical editors through ...
Trusted Source. . The CDC considers people ages 12 and up fully vaccinated if they’ve received one of the updated bivalent boosters. In other words, if you got one of the original booster shots ...
England step levels by district, from 17 May to 18 July 2021} Step 1 Step 2 Step 3 The Health Protection (Coronavirus, Restrictions) (Steps) (England) Regulations 2021 (SI 2021/364) is an English emergency statutory instrument which replaced The Health Protection (Coronavirus, Restrictions) (All Tiers) (England) Regulations 2020 from 29 March 2021.
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7] [8]